Biotech Medics Ne Stock One Year Return
| BMCS Stock | USD 0.01 0 12.41% |
Fundamental analysis of Biotech Medics allows traders to better anticipate movements in Biotech Medics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Biotech |
Biotech Medics Ne Company One Year Return Analysis
Biotech Medics' One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, Biotech Medics Ne has an One Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Biotech Fundamentals
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 9.68 M | |||
| Shares Outstanding | 172.36 M | |||
| Price To Earning | (0.47) X | |||
| Price To Sales | 3.30 X | |||
| Revenue | 469.8 K | |||
| Gross Profit | 408.14 K | |||
| EBITDA | 33.35 K | |||
| Net Income | (603.72 K) | |||
| Cash And Equivalents | 1.31 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | 0.02 X | |||
| Earnings Per Share | (0) X | |||
| Beta | 3.5 | |||
| Market Capitalization | 870.4 K | |||
| Total Asset | 5.08 M | |||
| Retained Earnings | (1.75 M) | |||
| Working Capital | (1.98 M) | |||
| Current Asset | 27 K | |||
| Current Liabilities | 2.01 M | |||
| Net Asset | 5.08 M |
About Biotech Medics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotech Medics Ne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotech Medics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotech Medics Ne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biotech Pink Sheet Analysis
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.